Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Letter: Pyridoxine and serum concentration of phenytoin and phenobarbitone.

Hansson O, Sillanpaa M.

Lancet. 1976 Jan 31;1(7953):256. No abstract available.

PMID:
55569
2.

Evaluation of serum levels during prolonged combination therapy with phenytoin and phenobarbitone.

Müller FO, Aucamp AK, Hundt HK, Steyn JM, Olivier LR, Wessels WH.

S Afr Med J. 1977 Aug 20;52(9):356-8.

PMID:
897947
3.

Phenytoin and phenobarbitone plasma clearance during pregnancy.

Mygind KI, Dam M, Christiansen J.

Acta Neurol Scand. 1976 Aug;54(2):160-6. No abstract available.

PMID:
821304
4.
5.

The binding of phenobarbitone and phenytoin to kwashiorkor serum.

Buchanan N, van der Walt LA.

S Afr Med J. 1977 Sep 17;52(13):518-21.

PMID:
72418
7.

The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levels.

Callaghan N, Feely M, Duggan F, O'Callaghan M, Seldrup J.

Acta Neurol Scand. 1977 Jul;56(1):1-6.

PMID:
878841
8.

Plasma level distribution, effect and toxicity of antiepileptic drugs among Ethiopian epileptics.

Bekele G, Abebe Y, T'Haimanot R.

Ethiop Med J. 1990 Jan;28(1):23-30.

PMID:
2307155
9.

Disappearance of phenobarbital and diphenylhydantoin from serum of children.

Garrettson LK, Dayton PG.

Clin Pharmacol Ther. 1970 Sep-Oct;11(5):674-9. No abstract available.

PMID:
5455632
10.

[Determination of serum levels of phenobarbital and diphenylhydantoin in the treatment of epilepsy].

Benetello P, Testa G, Furlanut M.

Clin Ter. 1978 Apr 15;85(1):11-8. Italian. No abstract available.

PMID:
657740
11.

Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.

Buchthal F, Svensmark O.

Psychiatr Neurol Neurochir. 1971 Mar-Apr;74(2):117-36. No abstract available.

PMID:
5004709
12.

Letter: Effect of phenytoin on serum phenobarbitone levels.

Cameron JD.

Br J Psychiatry. 1974 Nov;125:515-6. No abstract available.

PMID:
4461149
13.
14.

Serum levels of diphenylhydantoin and phenobarbital in epileptic children receiving diphenylhydantoin, phenobarbital and-or mysoline.

Yoshida T, Karahashi M, Tanabu M, Takagi T, Arakawa T.

Tohoku J Exp Med. 1974 Feb;112(2):169-75. No abstract available.

15.

Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy.

Lambie DG, Johnson RH, Nanda RN, Shakir RA.

Lancet. 1976 Aug 21;2(7982):386-9.

PMID:
73851
16.

Clinical value of determination of serum concentration of antiepileptics.

Wang L, Zuo QH, Liu SR, Wang SH.

Chin Med J (Engl). 1984 Mar;97(3):165-70. No abstract available.

PMID:
6432478
17.

Serum levels of anticonvulsants and haematological sequelae in black epileptics.

Buchanan N, Bill P, Strickwold B, Eyberg C, Moodley GP, Fernandes Costa F.

S Afr Med J. 1977 Apr 9;51(15):504-8.

PMID:
857325
18.

Monitoring of drug therapy in epileptic children.

Singh LM, Mehta S, Vohra RM, Nain CK.

Int J Clin Pharmacol Ther Toxicol. 1987 May;25(5):251-4.

PMID:
3596850
19.

[Determination of phenobarbital, mephenytoin and diphenylhydantoin in the surveillance of anticonvulsant treatment].

Maitrot B, Hue G, Canonne MA, Rocher A, Landriau N.

Ann Biol Clin (Paris). 1976;34(2):107-12. French.

PMID:
9890
20.

Supplemental Content

Support Center